Legend Biotech (LEGN) Net Margin: 2019-2025
Historic Net Margin for Legend Biotech (LEGN) over the last 7 years, with Sep 2025 value amounting to -14.12%.
- Legend Biotech's Net Margin fell 5581.00% to -14.12% in Q3 2025 from the same period last year, while for Sep 2025 it was -8.54%, marking a year-over-year decrease of 5463.00%. This contributed to the annual value of -28.22% for FY2024, which is 15353.00% up from last year.
- As of Q3 2025, Legend Biotech's Net Margin stood at -14.12%, which was up 71.00% from -48.70% recorded in Q2 2025.
- Legend Biotech's Net Margin's 5-year high stood at 2,153.59% during Q2 2022, with a 5-year trough of -738.96% in Q3 2021.
- In the last 3 years, Legend Biotech's Net Margin had a median value of 41.69% in 2024 and averaged 59.24%.
- Its Net Margin has fluctuated over the past 5 years, first soared by 260,623bps in 2022, then plummeted by 188,204bps in 2023.
- Legend Biotech's Net Margin (Quarterly) stood at -226.53% in 2021, then tumbled by 26,519bps to -491.72% in 2022, then surged by 30,947bps to -182.24% in 2023, then surged by 19,634bps to 14.09% in 2024, then plummeted by 5,581bps to -14.12% in 2025.
- Its Net Margin stands at -14.12% for Q3 2025, versus -48.70% for Q2 2025 and 51.74% for Q1 2025.